ANGIBAUD, PATRICK RENE,VENET, MARC GASTON,BOURDREZ, XAVIER MARC
申请号：
HU0104582
公开号：
HU229404B1
申请日:
1999.12.17
申请国别(地区):
HU
年份:
2013
代理人:
摘要：
This invention concerns compounds of formula the pharmaceutically acceptable acid addition salts and the stereochemically isomeric forms thereof, wherein -X<；SUP>；1<；/SUP>；-X<；SUP>；2<；/SUP>；-X<；SUP>；3<；/SUP>；- is a trivalent radical,； >；Y<；SUP>；1<；/SUP>；-Y<；SUP>；2<；/SUP>；- is a trivalent radical； r and s are each independently 0, 1, 2, 3, 4 or 5； t is 0, 1, 2 or 3； each R<；SUP>；1 <；/SUP>；and R<；SUP>；2 <；/SUP>；are independently hydroxy, halo, cyano, C<；SUB>；1-6<；/SUB>；alkyl, trihalomethyl, trihalomethoxy, C<；SUB>；2-6<；/SUB>；alkenyl, C<；SUB>；1-6<；/SUB>；alkyloxy, hydroxyC<；SUB>；1-6<；/SUB>；alkyloxy, C<；SUB>；1-6<；/SUB>；alkylthio, C<；SUB>；1-6<；/SUB>；alkyloxyC<；SUB>；1-6<；/SUB>；alkyloxy, C<；SUB>；1-6<；/SUB>；alkyloxycarbonyl, aminoC<；SUB>；1-6<；/SUB>；alkyloxy, mono- or di(C<；SUB>；1-6<；/SUB>；alkyl)amino, mono- or di(C<；SUB>；1-6<；/SUB>；alkylaminoC<；SUB>；1-6<；/SUB>；alkyloxy, aryl, arylC<；SUB>；1-6<；/SUB>；alkyl, aryloxy or arylC<；SUB>；1-6<；/SUB>；alkyloxy, hydroxycarbonyl, C<；SUB>；1-6<；/SUB>；alkyloxycarbonyl； or two R<；SUP>；1 <；/SUP>；or R<；SUP>；2 <；/SUP>；on adjacent positions form together a bivalent radical； R<；SUP>；3 <；/SUP>；is hydrogen, halo, C<；SUB>；1-6<；/SUB>；alkyl, cyano, haloC<；SUB>；1-6<；/SUB>；alkyl, hydroxyC<；SUB>；1-6<；/SUB>；alkyl, cyanoC<；SUB>；1-6<；/SUB>；alkyl, aminoC<；SUB>；1-6<；/SUB>；alkyl, C<；SUB>；1-6<；/SUB>；alkyloxyC<；SUB>；1-6<；/SUB>；alkyl, C<；SUB>；1-6<；/SUB>；alkylthio-C<；SUB>；1-6<；/SUB>；alkyl, aminocarbonylC<；SUB>；1-6<；/SUB>；alkyl, hydroxycarbonyl, hydroxycarbonylC<；SUB>；1-6<；/SUB>；alkyl, C<；SUB>；1-6<；/SUB>；alkyoxycarbonylC<；SUB>；1-6<；/SUB>；alkyl, C<；SUB>；1-6<；/SUB>；alkylcarbonylC<；SUB>；1-6<；/SUB>；alkyl, C<；SUB>；1-6<；/SUB>；alkyloxycarbonyl, aryl,
